2016 IMPAACT Annual Meeting Cure Scientific Committee Presentations

Welcome and Overview of Cure Committee Activities (Contact IMPAACT Operations Center)

Deborah Persaud

IMPAACT P1115 Update (Contact IMPAACT Operations Center)

Ellen Chadwick

Enlisting Effector Cells to Clear HIV Infection

David Margolis

Repeated TLR7 Agonist Treatment of SIV-Infected Monkeys on ART Can Induce Viral Remission (Contact IMPAACT Operations Center)

James Whitney and Romas Geleziunas

Virus-Specific T Cells after Transplant: Broadening Applicability to HIV

Michael Keller

PrEP Drug Pipeline – What Lies Beyond Truvada®? (Contact IMPAACT Operations Center)

Raphy Landovitz

Study update: IMPAACT 2009 - Pharmacokinetics, Adherence, Feasibility and Safety of Daily Tenofovir Oral PrEP During Pregnancy and Breastfeeding

Ben Chi

Getting to Zero - HIV Vaccines to Eliminate the Pediatric HIV-1 Epidemic

Sallie Permar

Study update: IMPAACT 2004 – Phase I Study to Determine Safety and Immunogenicity of Clade C ALVAC-HIV (vCP2438) in HIV-Exposed Infants

Sallie Permar

Study update: IMPAACT P1112 - Phase 1 Study to Determine Safety and PK Parameters of VRC01 in HIV-Exposed Infants (Contact IMPAACT Operations Center)

Coleen Cunningham

CAP 523: Alternative Vaccine Candidate CH505 (Contact IMPAACT Operations Center)

Giny Fouda

Study update: IMPAACT 1077 (PROMISE)

Mary Glenn Fowler

Next Steps for PMTCT

Maxie Owor